SU
Sagar Uppal
About Sagar Uppal
Data last updated:
Sagar Uppal is a Director at Syndicate Life Sciences Private Limited (since 2010) and Designated Partner at Elavitra Labs Llp (since 2018). The companies operate in Pharma and Information Technology. The largest current company by reported revenue is Syndicate Life Sciences Private Limited at ₹16.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Syndicate Life Sciences Private Limited U24233HR2010PTC040080 | Director | 15 Feb 2010 | 2010 | ₹16.12 Cr (FY 2025) | Active |
 Elavitra Labs Llp AAN-6264 | Designated Partner | 04 Dec 2018 | 2018 | Active |
Board colleagues of Sagar Uppal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nitin Bhayana | 02898201 | Syndicate Life Sciences Private Limited , Elavitra Labs Llp | Director |
| Madhuri Dubey | 08214336 | Elavitra Labs Llp | Designated Partner |
| Pragya Srivastava | 08214574 | Elavitra Labs Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sagar Uppal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagar Uppal
Sagar Uppal currently holds 2 directorships: Syndicate Life Sciences Private Limited (Director, since 15 Feb 2010, revenue ₹16.12 Cr (FY 2025)); Elavitra Labs Llp (Designated Partner, since 04 Dec 2018).
Sagar Uppal was first appointed on 15 Feb 2010 as Director at Syndicate Life Sciences Private Limited. The most recent appointment on record is 04 Dec 2018 at Elavitra Labs Llp.
The current boards of Sagar Uppal's companies include Nitin Bhayana (Syndicate Life Sciences Private Limited), Madhuri Dubey (Elavitra Labs Llp), Pragya Srivastava (Elavitra Labs Llp).